Identification |
Name: | 2H-1,2,4-Benzothiadiazine,7-chloro-3-methyl-, 1,1-dioxide |
Synonyms: | 4H-1,2,4-Benzothiadiazine,7-chloro-3-methyl-, 1,1-dioxide (7CI); 3-Methyl-7-chloro-1,2,4-benzothiadiazine1,1-dioxide; 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide;Diazoxide; Dizoxide; Eudemine injection; Hyperstat; Hypertonalum; Mutabase; NSC64198; NSC 76130; Proglicem; Proglycem; SRG 95213; Sch 6783 |
CAS: | 364-98-7 |
EINECS: | 206-668-1 |
Molecular Formula: | C8H7 Cl N2 O2 S |
Molecular Weight: | 230.66 |
InChI: | InChI=1/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11) |
Molecular Structure: |
|
Properties |
Flash Point: | 204.7°C |
Boiling Point: | 414.8°Cat760mmHg |
Density: | 1.61g/cm3 |
Refractive index: | 1.691 |
Biological Activity: | Antihypertensive, activates ATP-dependent K + channels. Induces activation of PKC ε , an intermediate in the opening of mitoK ATP channels, results in cardioprotection against hypoxia-induced death. Blocks desensitization of AMPA receptors. |
Flash Point: | 204.7°C |
Safety Data |
Hazard Symbols |
Xn: Harmful
|
|
|